CAI
Caris Life Sciences, Inc.
29.70$
+8.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.7% | 96.8% | -91.6% | -62.9% | -68.3% | -30.0% | -25.9% | 4.0% | 28.8% | 15.3% | 15.2% | 23.3% | 20.4% | |
| 34.4% | 32.6% | 21.9% | 11.6% | 12.2% | 8.4% | 5.8% | 3.5% | 2.2% | 1.5% | 2.3% | 4.4% | 2.6% | |
| 0.7% | 0.6% | 5.5% | 4.5% | 4.6% | 3.8% | 12.1% | 15.6% | 6.3% | 4.6% | 7.3% | 14.4% | 8.2% | |
| 32.6% | 21.4% | -1.5% | -4.1% | -18.9% | -1.3% | 11.0% | -0.8% | 6.5% | -20.2% | 3.8% | -6.9% | -5.5% | |
| 122.6% | 540.7% | 2.2% | 2.6% | 1.8% | 1.8% | 2.2% | 0.8% | 3.3% | 1.7% | 4.8% | 12.3% | 5.6% | |
| -97.4% | -511.1% | 73.9% | -2.6% | -1.8% | -1.8% | -2.2% | -0.8% | -3.3% | -1.7% | -4.8% | -50.3% | -15.7% | |
| 8.6% | 7.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | -7.6% | 0.0% | 0.0% | -8.1% | -3.8% | |
| – | – | 247.8% | 0.0% | – | – | 0.0% | 13.1% | 0.0% | 1.4% | 0.0% | -4.9% | -0.9% | |
| -14.1% | 425.3% | 248.0% | -0.1% | 0.1% | 0.2% | 1.1% | 375.6% | -9.7% | 1.2% | 0.4% | -13.7% | -5.4% | |
| -10.9% | 11.0% | 230.3% | -65.6% | -70.0% | -31.5% | -27.1% | 378.9% | 15.8% | 14.7% | 10.8% | -40.7% | -0.7% | |
| -21.9% | -443.9% | -93.8% | -65.5% | -70.1% | -31.7% | -28.1% | 3.3% | 25.5% | 13.6% | 10.4% | 11.0% | 14.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.